Ensemble machine learning identifies genetic loci associated with future worsening of disability in people with

Valery Fuh-Ngwa1, Yuan Zhou1, Phillip E Melton1

  • 1Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool St, Hobart, TAS, 7000, Australia.

Scientific Reports
|November 12, 2022
PubMed

Insights

This study identified seven genetic loci linked to multiple sclerosis disability progression. Ensemble genetic models can predict worsening disability in people with MS, aiding clinical decisions.

Area of Science:

  • Neurogenetics
  • Genomics
  • Biostatistics

Background:

  • Limited research exists on genetic factors influencing multiple sclerosis (MS) disability progression.
  • Identifying genetic markers for MS worsening is crucial for personalized medicine.

Purpose of the Study:

  • To identify MS genetic loci associated with disability worsening over time.
  • To develop and validate ensemble genetic learning models for predicting MS disability progression risk in individuals.

Main Methods:

  • Examined associations between 208 MS genetic loci and disability worsening risk.
  • Developed and validated ensemble genetic decision rules using an external dataset.
  • Utilized positional and eQTL mapping to identify genomic regions.

Main Results:

  • Identified 7 significant genetic loci associated with increased risk of disability worsening in MS.
  • These loci are located near or tag 13 genomic regions enriched in peptide hormone and steroid biosynthesis pathways.
  • Ensemble models generated genetic decision rules with prognostic value for clinical predictions.

Conclusions:

  • The study expands knowledge of MS progression genetics by identifying novel genetic loci.
  • The developed genetic decision rules can enhance clinical decision-making for people with MS (PwMS).
  • Findings provide a foundation for future research into the functional significance of identified MS genetic loci.